BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4691 related articles for article (PubMed ID: 6434180)

  • 1. Determination of cytotoxicity in vivo using 111indium-labeled human tumor cells.
    Lockshin A; Giovanella BC; Kozielski T; Stehlin JS
    Cancer Lett; 1984 Sep; 24(2):179-85. PubMed ID: 6434180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 111Indium labeling of cultured human tumor cells.
    Lockshin A; Mendoza JT; Giovanella BC; Stehlin JS
    Oncology; 1985; 42(5):322-7. PubMed ID: 3929199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo cytotoxicity assays with 111In-labeled tumor cells: comparison with [125I]iododeoxyuridine-labeled cells and effects of chelators and inoculation site.
    Lockshin A; Kozielski T; Stehlin JS
    Int J Rad Appl Instrum B; 1987; 14(5):515-21. PubMed ID: 3117739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of cytotoxicity with elimination of iodine-125 from nude mice inoculated with prelabeled human melanoma cells.
    Lockshin A; Giovanella BC; Quian C; Mendoza JT; Vardeman DM; Stehlin JS
    J Natl Cancer Inst; 1984 Aug; 73(2):417-22. PubMed ID: 6589433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of indium-111 in human malignant tumor xenografts and control by chelators.
    Watanabe N; Oriuchi N; Endo K; Inoue T; Tanada S; Murata H; Kim EE; Sasaki Y
    Nucl Med Biol; 1999 Oct; 26(7):853-8. PubMed ID: 10628568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of in vivo natural antitumor resistance and lymphocyte. Migration in mice: comparison of 125I-iododeoxyuridine with 111indium-oxine and 51chromium as cell labels.
    Wiltrout RH; Gorelik E; Brunda MJ; Holden HT; Herberman RB
    Cancer Immunol Immunother; 1983; 14(3):172-9. PubMed ID: 6404550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotoxicity of indium-111 oxine in mammalian cells.
    Kassis AI; Adelstein SJ
    J Nucl Med; 1985 Feb; 26(2):187-90. PubMed ID: 3918148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurements of cell-mediated cytotoxicity on target cells labelled with the indium-111-oxine complex.
    Smet-Donnay M; Guillaume M; Schaaf-Lafontaine N; Czichosz R; Firket H
    Ann Biol Clin (Paris); 1985; 43(3):285-8. PubMed ID: 3161437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [111In]oxine labelling of polymorphonuclear leucocytes: doubts concerning elution and effects on cell behaviour.
    Sheehan NJ; Brown KA; Camacho A; Dumonde DC
    Int J Nucl Med Biol; 1985; 12(3):243-7. PubMed ID: 3934095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of leukocytes labeled with indium-111-2-mercaptopyridine-N-oxide and indium-111 oxine for abscess detection.
    Intenzo CM; Desai AG; Thakur ML; Park CH
    J Nucl Med; 1987 Apr; 28(4):438-41. PubMed ID: 3106593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution studies of 111In-oxine-labeled peritoneal mononuclear cells in tumor-bearing rats.
    Abreo K; Lieberman LM; Moorthy AV
    Int J Nucl Med Biol; 1985; 12(1):53-5. PubMed ID: 3924848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CaNa2EDTA for improvement of radioimmunodetection and radioimmunotherapy with 111In and 90Y-DTPA-anti-CEA MAbs in nude mice bearing human colorectal cancer.
    Watanabe N; Oriuchi N; Endo K; Inoue T; Kuroki M; Matsuoka Y; Tanada S; Murata H; Kim EE; Sasaki Y
    J Nucl Med; 2000 Feb; 41(2):337-44. PubMed ID: 10688120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Labelling of lymphocytes with indium 111 oxine: effect on cell surface phenotype and antibody-dependent cellular cytotoxicity.
    Signore A; Beales P; Sensi M; Zuccarini O; Pozzilli P
    Immunol Lett; 1983 Mar; 6(3):151-4. PubMed ID: 6407981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of indium-oxine labelled red cells in haemolytic anaemias.
    Najean Y; Pommier Y; Deschryver F; Chomienne C
    Eur J Nucl Med; 1986; 12(8):379-80. PubMed ID: 3098565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of in vivo distribution of platelets labeled with indium-111 oxine.
    Heyns AD; Lötter MG; Kotzé HF; Pieters H; Wessels P
    J Nucl Med; 1982 Oct; 23(10):943-4. PubMed ID: 6811705
    [No Abstract]   [Full Text] [Related]  

  • 16. Improved tumor localization of 111In labeled monoclonal antibody with chelator administration to host nude mice.
    Lockshin A; Stehlin JS
    Eur J Nucl Med; 1987; 12(11):573-5. PubMed ID: 3106043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New 111In labeling of IgG: 111In-oxine mediated chelation.
    Cole WC; Leblanc AD; Jhingran SG
    Int J Rad Appl Instrum B; 1988; 15(2):177-9. PubMed ID: 3130338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient radiolabeling of mammalian cells using 111In-tagged liposomes.
    Kassis AI; Taube RA
    Int J Rad Appl Instrum B; 1987; 14(1):33-5. PubMed ID: 3108200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of contaminant indium-114m/indium-114 to indium-111 oxine blood dosimetry.
    Marcus CS; Stabin MG; Watson EE; Kuperus JH
    J Nucl Med; 1985 Sep; 26(9):1091-3. PubMed ID: 3928839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of 111In-oxine to 111In trichloride by acid hydrolysis.
    Wong DW
    Int J Rad Appl Instrum A; 1987; 38(1):70. PubMed ID: 3030971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 235.